Studying the association of plasma S100A12 and noninfectious pulmonary complication in infants and young children following cardiopulmonary bypass

( views:282, downloads:0 )
Author:
LIU Xi-wang(Department of Thoracic & Cardiovascular Surgery, Children's Hospital, Medical College, Zhejiang University, HangZhou 310003, China)
CHEN Qi-xing()
SHU Qiang(Department of Thoracic & Cardiovascular Surgery, Children's Hospital, Medical College, Zhejiang University, HangZhou 310003, China)
CHEN Chi(Department of Thoracic & Cardiovascular Surgery, Children's Hospital, Medical College, Zhejiang University, HangZhou 310003, China)
SHI Shan-shan(Department of Thoracic & Cardiovascular Surgery, Children's Hospital, Medical College, Zhejiang University, HangZhou 310003, China)
SHI Zhuo(Department of Thoracic & Cardiovascular Surgery, Children's Hospital, Medical College, Zhejiang University, HangZhou 310003, China)
YU Jian-gen(Department of Thoracic & Cardiovascular Surgery, Children's Hospital, Medical College, Zhejiang University, HangZhou 310003, China)
LIN Ru(Department of Thoracic & Cardiovascular Surgery, Children's Hospital, Medical College, Zhejiang University, HangZhou 310003, China)
TAN Lin-hua(Department of Thoracic & Cardiovascular Surgery, Children's Hospital, Medical College, Zhejiang University, HangZhou 310003, China)
Journal Title:
Chinese Journal of Emergency Medicine
Issue:
Volume 21, Issue 10, 2012
DOI:
10.3760/cma.j.issn.1671-0282.2012.10.017
Key Word:
S100A12; Soluble advanced glycation end products (sRAGE); Noninfectious pulmonary complication (NPC) ; Cardiopulmonary bypass; cardiac surgery; Congenital heart disease; Infant and young children ; Case-control; Correlation.

Abstract: Objective To examine the kinetics of plasma S100A12 and soluble receptor for advanced glycation end products (sRAGE) in infants and young children undergoing cardiopulmonary bypass ( CPB),and to investigate whether they could protective the occurrence of noninfectious pulmonary complication (NPC) after cardiac surgery.Methods This was a case-control study.The subjects included all children aged <3 years old who underwent cardiac surgery with CPB during the period from June 1st to July 31st 2011.The patient who showed pulmonary inflammation or had abnormal liver or renal function before surgery was excluded.The remain patients were divided into 2 groups according to whether they had developed NPC postoperatively.Twenty patients were grouped into NPC because they developed the complications of pleural effusion,chylothorax,partial lung collapse,pulmonary hypertensive crisis,airway disorders,pneumothorax,pneumomediastinum,or phrenic nerve palsy.Forty patients were categorized into the no-NPC group.Plasma concentrations of S100A12 and sRAGE were measured using ELISA at baseline,before CPB,immediately after CPB,1 h,12 h and 24 h after operation.Differences concentrations between two groups were analyzed with t test.A stepwise logistic regression analysis was used to indentify the independent risk factor for NPC.A P value <0.05 was considered statistically significant.Results Plasma levels of S100A12 and sRAGE dramatically increased immediately after CPB ( P < 0.01 ).The levels of sRAGE dropped to lower than baseline level (P <0.05),while S100A12 was still at high level 24h after operation (P <0.01 ).Levels of S100A12 and sRAGE immediately after CPB in NPC group were significantly higher than the no-NPC group (P < 0.05).Twenty-four hours after operation,levels of S100A12 were still higher in NPC group than no-NPC (P < 0.01 ),while levels of sRAGE were similar in the two groups ( P > 0.05 ).In the stepwise logistic regression analysis,plasma S100A12 level immediately after CPB remained as a independently predictor for postoperative NPC (OR =1.042,95% CI:1.010 ~ 1.076,P =0.011 ).Levels of S100A12 immediately after CPB were positively associated with mechanical ventilation time ( r =0.47,P < 0.01 ),duration of surgical Intensive Care Unit ( r =0.407,P =0.002) and hospital stay ( r =0.421,P =0.01 ).Conclusions Plasma levels of S100A12 and sRAGE were significantly increased immediately after CPB and the elevated plasma S100A12 immediately after CPB served as an early reliable biomarker of the occurrence and the prognosis of NPC after CPB in infants and young children.

  • [1]Polito A,Patorno E,Costello JM,et al. Perioperative factors associated with prolonged mechanical ventilation after complex congenital heart surgery[J].Pediatr Crit Care Med,2011,12(3):e122-126.
  • [2]Ip P,Chiu CS,Cheung YF.Risk factors prolonging ventilation in young children after cardiac surgery: Impact of noninfectious pulmonary complications[J].Pediatr Crit Care Med,2002,3(3):269-274.
  • [3]Pietzsch J,Hoppmann S.Human S100A12:a novel key player in inflammation[J].Amino Acids,2009,36 (3):381-389.
  • [4]Hofmann MA,Drury S,Fu C,et al. RAGE mediates a novel proinflammatory axis:a central cell surface receptor for S100/calgranulin polypeptides[J].Cell,1999,97 (7):889-901.
  • [5]Wittkowski H,Sturrock A,van Zoelen MA,et al. Neutrophil-derived S100A12 in acute lung injury and respiratory distress syndrome[J].Crit Care Med,2007,35 (5):1369-1375.
  • [6]Shi S,Zhao Z,Liu X,et al.Perioperative risk factors for prolonged mechanical ventilation following cardiac surgery in neonates and young infants[J].Chest,2008,134 (4):768-774.
  • [7]Bandla HP,Hopkins RL,Beckerman RC,et al.Pulmonary risk factors compromising postoperative recovery after surgical repair for congenital heart disease[J].Chest,1999,116 (3):740-747.
  • [8]Paparella D,Yau TM,Young E.Cardiopulmonary bypass induced inflammation:pathophysiology and treatment.An update[J].Eur J Cardiothorac Surg,2002,21 (2):232-244.
  • [9]杨维君,张泽伟,林茹,等.含乌司他丁肺保护液在心肺转流术中的肺保护作用[J].中华急诊医学杂志,2009,18(6):594-597.
  • [10]赵琦峰,王胜利,胡型锑.小儿体外循环术中抑肽酶促进内源性白细胞介素-10释放的研究[J].中华急诊医学杂志,2005,14 (2):144-147.
  • [11]Buckley ST,Ehrhardt C.The receptor for advanced glycation end products (RAGE) and the lung[J].J Biomed Biotechnol,2010,917108:1-11.
  • [12]Creagh-Brown BC,Quinlan GJ,Evans TW,et al.The RAGE axis in systemic inflammation, acute lung injury and myocardial dysfunction:an important therapeutic target[J].Intensive Care Med,2010,36 (10):1644-1656.
  • [13]Chavakis T,Bierhaus A,Al-Fakhri N,et al. The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins:a novel pathway for inflammatory cell recruitment[J].J Exp Med,2003,198 (10):1507-1515.
  • [14]Adembri C,Kastamoniti E,Bertolozzi I,et al.Pulmonary injury follows systemic inflammatory reaction in infrarenal aortic surgery[J].Crit Care Med,2004,32 (5):1170-1177.
  • [15]Kikkawa T,Sato N,Kojika M,et al.Significance of measuring S100A12 and sRAGE in the serum of sepsis patients with postoperative acute lung injury[J].Dig Surg,2010,27 (4):307-312.
  • [16]Adembri C,Kastamoniti E,Bertolozzi I,et al.Pulmonary injury follows systemic inflammatory reaction in infrarenal aortic surgery[J].Crit Care Med,2004,32 (5):1170-1177.
  • [17]Worrall NK,Chang K,LeJeune WS,et al.TNF-alpha causes reversible in vivo systemic vascular barrier dysfunction via NO-dependent and-independent mechanisms[J]. Am J Physiol,1997,273 (6/2):H2565-2574.
  • [18]Seghaye MC.The clinical implications of the systemic inflammatory reaction related to cardiac operations in children[J]. Cardiol Young,2003,13 (3):228-239.
  • [19]Hudson BI,Stickland MH,Futers TS,et al. Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy[J].Diabetes,2001,50 (6):1505-1511.
  • [20]Hanford LE,Enghild JJ,Valnickova Z,et al.Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE)[J].J Biol Chem,2004,279 (48):5019-5024.
  • [21]Kamioka M,Ishibashi T,Ohkawara H,et al. Involvement of membrane type 1-matrix metalloproteinase (MT1-MMP) in RAGE activation signaling pathways[J]. J Cell Physiol,2011,226(6):1554-1563.
  • [22]Bandla HP,Hopkins RL,Beckerman RC,et al.Pulmonary risk factors compromising postoperative recovery after surgical repair for congenital heart disease[J].Chest,1999,116 (3):740-747.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn